About the Journal
European Urology, 'The Platinum Journal', published continuously since 1975, is an international peer-reviewed journal devoted to urology and related sciences and is published monthly. European Urology is the official journal of the European Association of Urology (EAU), a scientific society with more than 15,000 members from 120 countries worldwide. European Urology is available both in print and online and reaches over 20,000 readers. The Editor-in-Chief of European Urology is Professor Francesco Montorsi.
European Urology's 2011 impact factor is 8.493. The impact factor is a measure of the citation rate per article, and is calculated by dividing 1 year's worth of citations to a journal's articles published in the previous 2 years by the number of articles published by that journal in those 2 years. European Urology's acceptance rate is approximately 10% of the nearly 2000 solicited and unsolicited original manuscripts it receives annually; its average time from submission to first editorial decision is approximately 12 days.
Each month European Urology publishes a wide variety of articles in all areas of urology and related sciences. The journal publishes review articles, original articles, Surgery in Motion articles with the accompanying video available online, editorials, editorial comments, interviews, debates, Words of Wisdom, Letters to the Editor, and case series.
EU-ACME accredited questions are included in every issue of European Urology and can be answered at http://www.eu-acme.org/europeanurology.
Manuscripts should be submitted online via the European Urology online manuscript submission and review system at http://ees.elsevier.com/eururol
Statements in articles or opinions expressed by any contributor in any article are not the responsibility of the editors or the publishers. The publisher is not responsible for the loss of manuscripts through circumstances beyond its control.
Accepted manuscripts will be copyedited to make sure they conform to the journal's style. The final version of the manuscript following copyediting will be sent back to the author only if specific queries need clarification.
English Language Standard
Authors whose native language is not English are expected to have their manuscripts proofread by a professional copyeditor of their choice before submission. Dragonfly Editorial is the official copyeditor for European Urology (www.dragonflyeditorial.com)
Supplementary Files and Data
Information necessary for the article that is in excess of the manuscript restrictions, will be considered for on line publication or storage. Examples include extensive methodological descriptions, tables of data that are supplementary to the main article thread, details of reporting standards (such as CONSORT flow charts) and other useful figures. This information is to be submitted with the main manuscript and clearly labeled as Supplementary. It will be reviewed by the editorial office and peer reviewers to ensure that it is well presented in an acceptable format and that the contents are necessary. Please use the European Urology formatting style for references and presentation.
Editorial Office Contact Information
Questions regarding manuscript submission may be sent to:
European Urology Editorial Office
Ms. Cathy Pierce Editorial Office Manager
Via Stamira d'Ancona 20
20127 Milan Italy
Telephone: +39 02 2643 6438
Telephone: +39 02 2643 6432
Fax: +39 02 2643 6450
Authorship Criteria and Contributions and Authorship Form
Completion and inclusion of the Authorship Responsibility, Financial Disclosure and Acknowledgment Form is an obligatory step of the submission process for Original Articles, Review Articles and Surgery in Motion articles. A standard disclosure stating conflicts of interests, if any, can be uploaded for letters to the editor, editorials, words of wisdom and case reports.
If the form is not completed as instructed below, the manuscript will not be considered for peer review.
The corresponding author must submit the above mentioned completed form on behalf of all co-authors, if any. Download form here: authorship form.
The corresponding author must take responsibility for the integrity of the work as a whole, from inception to published article. Each collaborating author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Authorship credit should be based on: substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting of the article or revising it critically for important intellectual content, statistical analysis, obtaining funding, administrative, technical or material support, supervision and any other specifics to be declared at publication. The corresponding author is obliged to indicate the co-authors contribution to the manuscript in the appropriate field in the said form.
Each co-author's specific contribution for reports of original data and systematic reviews will be included with the published manuscript.
Each field may include more than one author.
Role of the Corresponding Author
The corresponding author will serve on behalf of all co-authors as the primary correspondent with the editorial office during the submission and review process. If the manuscript is accepted, the corresponding author will review an edited typescript and proof and will be identified as the corresponding author in the published article. The corresponding author is responsible for ensuring that all information included in the Authorship Responsibility, Financial Disclosure and Funding Support form and the Acknowledgment section, if any, is complete and has been agreed on by all authors. ''Acknowledgment'' is the general term for the list of contributions, credits, and other information included at the end of the text of a manuscript before the references.
If authorship is attributed to a group (either solely or in addition to one or more individual authors), all members of the group must meet the full criteria and requirements for authorship as described above. If that is not the case, a group must designate one or more individuals as authors or members of a writing group who meet full authorship criteria and requirements. Other group members who are not authors may be listed in an Acknowledgment.
Conflicts of Interest and Financial Disclosures
A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or manuscript.
Authors are expected to provide detailed information about all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests (such as patent applications in preparation), that represent potential future financial gain.
For example, authors of a manuscript about prostate cancer should report all financial relationships they have with all manufacturers of products used in the management of prostate cancer, not only those relationships with companies whose specific products are mentioned in the manuscript.
Although many universities and other institutions have established policies and thresholds for reporting financial interests and other conflicts of interest, European Urology requires complete disclosure of all relevant financial relationships and potential financial conflicts of interest, regardless of amount or value.
All disclosures of any potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript will be disclosed by the corresponding author on behalf of each co-author, if any, as part of the submission process. Likewise, authors without conflicts of interest, will be requested to state so as part of the submission process.
If authors are uncertain about what constitutes a relevant financial interest or relationship, they should contact the editorial office.
Failure to include this information in the manuscript will prohibit commencement of the review process of the manuscript.
For all accepted manuscripts, each author's disclosures of conflicts of interest and relevant financial interests and affiliations and declarations of no such interests will be published.
The policy requesting disclosure of conflicts of interest applies for all manuscript submissions. If an author's disclosure of potential conflicts of interest is determined to be inaccurate or incomplete after publication, a correction will be published to rectify the original published disclosure statement.
Authors are also required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies as part of the submission process. For all accepted manuscripts, each author's source of funding will be published.
Funding/Support and Role of Sponsor
All financial and material support for the research and work will be requested to be clearly and completely identified as part of the submission process. The specific role of the funding organization or sponsor in each of the following should be specified: ''design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.'' The corresponding author is responsible for acknowledging this on the authorship form at the time of submission.
Data Access and Responsibility
For all reports (regardless of funding source) containing original data, at least one named author (e.g., the principal investigator) who is independent of any commercial funder should indicate that she or he ''had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.'' This exact statement will be requested as part of the submission process. Modified statements or generic statements indicating that all authors had such access are not acceptable.
For authors reporting molecular results derived using high throughput technologies we support the use of minimum reporting standards. For example, for microarrays we support the use of the MIAME 2.0 standards, for deep sequencing we support MIN-Seq and for realtime PCR we support the MICQ guidelines. Details of these are available at http://www.mged.org/index.html or http://miqe.gene-quantification.info/. We require that datasets derived from these experiments and used for reports within European Urology are deposited on line at the appropriate repositories (such as ArrayExpress (www.ebi.ac.uk/arrayexpress/) or GEO, NCBI (http://www.ncbi.nlm.nih.gov/geo/).
Duplicate/Previous Publication or Submission
Manuscripts are considered with the understanding that they have not been published previously in print or electronic format and are not under consideration by another publication or electronic medium. Copies of related or possibly duplicative materials (ie, those containing substantially similar content or using the same or similar data) that have been previously published or are under consideration elsewhere must be provided at the time of manuscript submission.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, formal review and approval, or review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations of human subjects, state in the Methods section the manner in which informed consent was obtained from the study participants (ie, oral or written).
Personal Communications and Unpublished Data
A signed statement of permission should be included from each individual identified as a source of information in a personal communication or as a source for unpublished data, and the date of communication and whether the communication was written or oral should be specified.
Previous Presentation or Release of Information
A complete report following presentation at a meeting or publication of preliminary findings elsewhere (e.g., an abstract) is eligible for consideration for publication.
Published manuscripts become the permanent property of the EAU and may not be published elsewhere in whole or in part without written permission. Unauthorized use of the European Urology name, logo, or any content for commercial purposes or to promote commercial goods and services (in any format, including print, video, audio, and digital) is not permitted by the EAU.
Editorial Review and Publication
Authors will be sent notifications of the receipt of manuscripts and editorial decisions by e-mail. During the review process, authors can check the status of their submitted manuscript via the online manuscript submission and review system.
Editorial and Peer Review
All submitted manuscripts are reviewed initially by the European Urology Editor-in-Chief and Associate Editors. Manuscripts submitted for the Surgery in Motion section will also undergo peer review, supervised by the Editor-in-Chief and the Surgery Editor and must be submitted along with the accompanying video (please see ''Types of Articles'' section below).
Manuscripts are evaluated according to the following criteria: material is original and timely, writing is clear, study methods are appropriate, data are valid, conclusions are reasonable and supported by the data, information is important, and the topic has general interest for urologists. From these basic criteria, the editors decide whether a manuscript reaches a priority score to justify peer review. Manuscripts with insufficient priority for publication are rejected promptly. Manuscripts which have not be straight rejected are sent to expert consultants for peer review. Although rare, it is possible for an exceptional manuscript to be accepted upon submission.
Manuscripts considered to be of interest by the editors will be peer reviewed by internationally recognized experts on the subject. Each manuscript is sent to 3 - 8 reviewers. When necessary, a biostatistician will also review manuscripts. A copy of the study protocol may be requested during the review process.
Reviewers are matched to the paper according to their expertise. Our reviewer database is constantly being updated to ensure the reviewer profile matches that of the topic being discussed in the manuscript. We welcome suggestions for reviewers from the author though these recommendations may or may not be considered.
Please find here an example of what aspects of the manuscript the reviewers are asked to evaluate after having read the manuscript, click to view new reviewer template. Please note that this guideline is designed to help in the review process and is not mandatory.
Essentially, reviewers are asked to evaluate whether the manuscript:
- Is original
- Is methodologically sound
- Follows appropriate ethical guidelines
- Has results that are clearly presented and support the conclusions
- Correctly references previous relevant work
- Is aimed at the journal's target readership
Reviewers are not expected to correct or copyedit manuscripts. Language correction is not part of the peer-review process.
Reviewers are allotted 10 days to complete their reviews. The reviewers are not blinded to the names of the authors or the institution from which the manuscripts have been submitted.
Final Editorial Decision
The final decision to accept, revise, or reject a manuscript is made by the Editor-in-Chief after carefully considering the opinion of the Associate Editor(s) handling that particular manuscript. The decision is sent to the author along with any recommendations made by the reviewers and editors.
Prior to submitting a manuscript to European Urology, authors must ensure that each requirement listed below is met. Manuscripts that do not meet these requirements will be returned to the author without review.
Accepted manuscripts are edited in accordance with the journal in-house style. Authors are expected to be responsible for all statements made in their work, including changes made during editing and production that are authorized by the corresponding author.
Requests to publish corrections should be sent to the editorial office. Corrections are reviewed by editors and authors, published promptly, and linked online to the original article.
Offprints may be ordered when the edited typescript is sent for approval to the corresponding author. Additional copies (minimum 100) can be ordered at prices quoted on the order form that will be sent with the acknowledgment letter.
Types of Articles
These manuscripts typically report on basic and translational research, epidemiology, pathophysiology, diagnosis, medical or surgical treatment, and minimally invasive therapy related to urologic diseases.
Each manuscript should clearly state an objective or hypothesis; the design and methods (including the study setting and dates, patients or participants with inclusion and exclusion criteria and/or participation or response rates, or data sources, and how these were selected for the study); the essential features of any interventions; the main outcome measures; the main results of the study; a discussion section placing the results in context with the published literature and addressing study limitations; and the conclusions. Data included in research reports should be as timely and current as possible.
Abstract example here
The format of the original article should be as follows:
Provide a structured abstract no longer than 300 words with the following sections: Background; Objective; Design, Setting, and Participants; Intervention (include if there are any); Outcome Measurements and Statistical Analysis; Results and Limitation; Conclusions.
For brevity, parts of the abstract may be written as phrases rather than complete sentences. Each section should include the following content (see abstract structure details below):
- Background: The abstract should begin with a sentence or two explaining the clinical (or other) importance of the study question.
- Objective: State the precise objective or study question addressed in the manuscript (e.g., ''To determine whether. . .''). If more than one objective is addressed, the main objective should be indicated and only key secondary objectives stated.
- Design, Setting, and Participants: Describe the basic design of the study. State the years of the study and the duration of follow-up. Describe the study setting to assist readers to determine the applicability of the report to other circumstances, for example, general community, a primary care or referral center, private or institutional practice, or ambulatory or hospitalized care. State the clinical disorders, important eligibility criteria, and key sociodemographic features of patients. The numbers of participants and how they were selected should be provided. In follow-up studies, the proportion of participants who completed the study must be indicated. In intervention studies, the number of patients withdrawn because of adverse effects should be given. For selection procedures, these terms should be used, if appropriate: random sample (where random refers to a formal, randomized selection in which all eligible individuals have a fixed and usually equal chance of selection); population-based sample; referred sample; consecutive sample; volunteer sample; convenience sample.
- Intervention(s): The essential features of any interventions (surgical or medical) should be described. The nonproprietary drug or device names should be used unless the specific trade name is essential to the study.
- Outcome Measurements and Statistical Analysis: Indicate the primary and secondary study outcome measurement(s) and the main statistical analysis.
- Results and Limitations: The main outcomes of the study should be reported and quantified. Complications or sequelae of the interventions used must be detailed. Particular attention must be paid to estimates of treatment effect and confidence intervals and not just to p-values. All randomized controlled trials should include the results of intention-to-treat analysis, and all surveys should include response rates. Limitations of the study should be acknowledged.
- Conclusions: Provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization. Indicate whether additional studies are required before the results should be used in usual clinical settings. Give equal emphasis to positive and negative findings of equal scientific merit.
Trial Registration: For clinical trials, the name of the trial registry, registration number, and URL of the registry must be included.
The text of the manuscript should be divided as follows: Introduction; Material (Patients) and Methods; Results; Discussion; Conclusions.
Number of references should be limited to 30.
Maximum word count is 2800, including the abstract but not including the references, tables, figures, or legends. (Abstract Maximum 300 words. Text Maximum 2500)
Take Home Message
Two or three sentences (no more than 40 words) summarizing the main message expressed in the article must be uploaded as a separate file.
Ethical Considerations and Registration of Clinical Trials
Trial Registration: As a member of the International Committee of Medical Journal Editors (ICMJE), European Urology requires, as a condition of consideration for publication, registration of all trials in a public trials registry that is acceptable to the ICMJE and that requires the minimum registration data set as described by the ICMJE.
Acceptable trial registries include the following:
For this purpose, a clinical trial is any study that prospectively assigns human subjects to intervention or comparison groups to evaluate the cause and- effect relationship between a medical/surgical intervention and a health outcome. All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. For clinical trials starting patient enrollment after July 2005, trials must be registered before onset of enrollment. Trial registry name, registration identification number, and the URL for the registry should be included at the end of abstract.
CONSORT Flow Diagram and Checklist: Manuscripts reporting the results of randomized controlled trials should include the CONSORT flow diagram showing the progress of patients throughout the trial. The CONSORT checklist also should be completed and submitted with the manuscript and can be found on http://www.consort-statement.org/consort-statement/.
Surgery in Motion
Authors are welcome to submit manuscripts describing particular surgical techniques. In addition to describing the technique in detail, early and long term results and complications must be reported as well. Mandatory requirements include a minimum number of 10 patients who have undergone the procedure in discussion and with a minimum 1-year follow-up of all patients. Authors are encouraged to include professional sketches describing the key steps of the surgical procedures. Examples of suitable sketches can found on see Stolzenburg.
In order to be considered eligible for the Surgery in Motion section, each manuscript must be accompanied by an explanatory video. Sending the video as an electronic file through our dedicated FTP server is preferred. Please contact the editorial office at: email@example.com for uploading instructions. If you would prefer to send the video via post, digital files (miniDV, DV, DVD, DVCAM, DVCPRO) are the preferred format, but the journal also accepts Betacam, Digital 8 or MPEG2, MPEG4, and Quicktime Files. The duration of the video should be 10 to 15 minutes, and audio should be provided as well. Please send 3 copies of the DVD to the editorial office.
Click here to view the Surgery in Motion Video Guideline!
The format of these manuscripts should follow the guidelines for original articles with the exception of the abstract.
a structured abstract no longer than 300 words with the following
sections: Background; Objective; Design, Setting, and Participants;
Surgical Procedure; Measurements; Results and Limitations; Conclusions.
For brevity, parts of the abstract may be written as phrases rather than complete sentences.
See example of a structured abstract here
- Background: The abstract should begin with a sentence or two explaining the importance of and the need for the described surgical procedure.
- Objective: State the precise objective addressed in the manuscript (e.g., ''To show the efficacy and safety of. . .'').
- Design, Setting, and Participants: Describe the basic design of the study. State the years of the study and the duration of follow-up. Describe the study setting to assist readers to determine the applicability of the report to other circumstances, for example, office-based/private urologists vs. hospital/academic urologists. State the number, clinical characteristics, and important inclusion/ exclusion criteria of patients.
- Surgical Procedure: The essential features of the
operation should be described. The nonproprietary device names should be
used unless the specific trade name is essential to the study.
Measurements: Indicate the primary and secondary study outcome measurement(s).
Results and Limitations: The main outcomes of the study should be reported and quantified.
- Complications or sequelae of the procedure used must be detailed. Limitations of the study must be acknowledged.
- Conclusions: Provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization. Indicate whether additional study is required before the information should be used in usual clinical settings.
- Give equal emphasis to positive and negative findings of equal scientific merit.
- Examples of how a Surgery in Motion abstract should be structured see example of a structured abstract.
The text of the manuscript should be divided as follows: Introduction; Patients and Methods (a sub-section called ''Surgical Technique'' must be included in this section); Results; Discussion; Conclusions.
Number of references should be limited to 30.
Maximum word count is 3000, including the abstract but not including the references, tables, figures, or legends.
Take Home Message
Two or three sentences (no more than 40 words) summarizing the main message expressed in the article must be uploaded as a separate file. This text will be used on the contents page, and it should stimulate the reader to read through the full text of the article.
European Urology aims at publishing mainly systematic reviews (and meta-analyses, whenever appropriate). These are reviews that systematically find, select, critique, and synthesize evidence relevant to well defined questions about diagnosis, therapy, and prognosis. Manuscripts reporting systematic review and meta-analysis should comply with the PRISMA statement. Such review articles are in principle solicited by the editorial board. Authors who would like to submit unsolicited systematic review articles should first write to the editorial office describing the content of the review article they wish to submit. Review articles should not be submitted in full without prior approval from the editors.
The format of the review article should be as follows:
Provide a structured abstract no longer than 300 words with the following sections: Context, Objective, Evidence Acquisition, Evidence Synthesis, Conclusion.
Context: Include one or two sentences describing the
clinical question or issue and its importance in clinical practice or
Objective: State the precise primary objective of the review. Indicate whether the review emphasizes factors such as cause, diagnosis, prognosis, therapy, or prevention and include information about the specific population, intervention, exposure, and tests or outcomes that are being reviewed.
Evidence Acquisition: Describe the data sources used, including the search strategies, years searched, and other sources of material, such as subsequent reference searches of retrieved articles. Methods used for quality assessment and inclusion of identified articles should be explained. Evidence Synthesis: The major findings of the review of the clinical issue or topic should be addressed in an evidence-based, objective, and balanced fashion, with the highest quality evidence available receiving the greatest emphasis.
Conclusions: The conclusions should clearly answer the questions posed if applicable, be based on available evidence, and emphasize how clinicians should apply current knowledge.
See example of a structured abstract here.
The text of the manuscript should be divided as follows: Introduction, Evidence Acquisition, Evidence Synthesis, Conclusions.
Maximum word count is 4000, including the abstract but not including the references, tables, figures, or legends.
Number of references should be limited to 50.
Take Home Message
Two or three sentences (no more than 40 words) summarizing the main message expressed in the article must be uploaded as a separate file.
Case Series of the Month
Please note that we no longer consider single case studies.
This section is dedicated to publishing promising studies which have only preliminary results at this stage.
We ask that your Case Series reports on no more than 10 patients and include illustrative images.
The Case Series should be as follows: an unstructured abstract of no more than 200 words, the case series, the discussion and a maximum of 10 references. The text must be accompanied by 4 to 6 figures or photos which will be published on the front cover of the journal. The 1500 word count limit includes the abstract and the body but not the figures, tables, legends or references.
Please also include a CME question with 4 multiple choice answers. The question will be published at the end of the article and made available on our dedicated CME website. The questions and answers will not be published in the same issue but will be available on the website: http://www.eu-acme.org/europeanurology/
These are commentaries on current topics or on papers published elsewhere in the issue. Word count limit is 1500 and 10 references are allowed. All editorials are solicited by the editors and should not be submitted without prior written approval.
Reviews of books, journals, and new media are solicited by the editor.
Words of Wisdom
The Words of Wisdom contributions are by invitation only. If you are interested in submitted a piece for consideration in this section, please contact the Editorial Office.
Letters to the Editor
Letters to the Editor are considered for publication (subject to editing and abridgment) provided they do not contain material that has been submitted or published elsewhere. They must be submitted online via EES http://ees.elsevier.com/eururol/
Please note that European Urology considers two different types of Letters to the Editor.
Letters to the Editor about a recent journal article
Letters referring to a recent journal article must be received within three months of its publication. For example, a letter referring to an article published in the January issue must be submitted online no later than March 31st. Letters submitted after the allowed time will not be considered. The text, not including references, must not exceed 500 words. A maximum of three authors and five references are allowed. Neither tables nor figures are allowed.
Letters to the Editor NOT referring to a recent journal Article
Original research that is of interest but does not fulfil all the requirements needed for publication as a full-length manuscript can be submitted as a letter to the editor. The letter must have a title and a maximum of three authors.
The text, not including references, tables, figures or legends must not exceed 500 words. No more than five references and either one table or one figure are allowed.
Residents Corner Articles
This section is reserved for original articles for which the first author is a resident in training. Authors should provide official certification of resident status when submitting an article for this specific section of the journal. Manuscripts must adhere to the instructions for author for Original Articles (see above). The two best papers published in this section during the calendar year will be awarded a special prize during the European Urological Association annual meeting.
For new findings of sufficient importance to justify accelerated review and publication, a fast-track submission process for original articles is available. In the submission letter, authors should explicitly request this option and provide credit card information (number, expiration date, and name as it appears on the card). If the editors agree that the manuscript is worthy of fast-track publication, the fee of 300 Euros will be automatically charged to the credit card. If accepted for fast-track submission, an article will be reviewed within 72 hours (otherwise, authors will be informed that the paper will be handled within the normal peer-review process). If accepted, a fast-track submission will appear in the first available issue of the journal.
Platinum Slide Series
"The Platinum Slide Series" is a summary of the text and images of each published article distributed over several power point slides. These slides are available on the European Urology website (www.europeanurology.com) for users to download and include in their presentations for free. Citation information is included automatically on each slide.
"The Platinum Slide Series" gives your published article even more exposure while at the same time allowing other researchers to improve their presentations, lectures and lessons by directly referencing your published results.
In order to make sure that your published article offers these slides, we kindly ask that, upon acceptance of your article, you send us a word document listing the following in no more than 100 words for each point.
(400 words in total):
- Material & Methods
Please include a title page containing the full title of the article, the authors and their affiliations. Please do not include figures and tables as they will be included automatically by the system. The citation information will be added to the slides once this information is available.
Please find below an example of the information needed to ensure that your Platinum slides will be available for others to use:
Three articles per issue are selected by the Editor-in- Chief as EU-ACME articles. These articles are highlighted as such in the table of contents of both the printed and online version of the journal and on the first page of the article. Upon request, authors must provide six EU-ACME questions based on the information provided in the article with the submission. Four possible answers must be provided for each question, with only one of them being correct. The correct answer should be explained in text limited to 50 words; up to three references are allowed to support this explanation. (Specifically dedicated instructions for authors for these questions and answers will be provided.) The questions and answers will not be printed in the journal but will be available on the website http://www.eu-acme.org/europeanurology/
Manuscript Preparation and Submission Requirements
"European Urology follows the EQUATOR network resource centre guidance on good research reporting (http://www.equator-network.org/)."
Click here for a list of useful reporting guideline websites which European Urology recommends
Original manuscripts written in English should be submitted through the web site of our online submission system, EES (http://ees.elsevier.com/eurorol), in Word, WordPerfect, or LaTeX formats for text and EPS or TIFF for illustrations. Authors may also check the status of submitted articles at this site. At the time of submission, complete contact information (postal/mail address, e-mail address, telephone and fax numbers) for the corresponding author is required. First and last names, e-mail addresses, and institutional affiliations of all coauthors are also required. Manuscripts submitted through the online system should not also be submitted by mail or e-mail. Once the manuscript is submitted online, the corresponding author will receive a manuscript number and will be able to follow the status of the manuscript through the online system.
Include a title page, abstract, text, references, and as appropriate, figure legends, tables, and figures, take home message (for original and review articles) and authorship form (authorship form can be downloaded at authorship form).
Start each of these sections on a new page, numbered consecutively, beginning with the title page. Please check the instructions per article type listed above.
Manuscript File Formats
For submission and review, acceptable manuscript file formats include Word, WordPerfect, EPS, Text, Postscript, or RTF format. Use 12-point font size, double-space text, and leave right margins unjustified with margins of at least 2.5 cm. Each page should be numbered in the upper right corner, beginning on p. 2. Add continuous line numbering.
The title page should include a word count for the text and abstract separately. Authors full names, highest academic degrees, and affiliations should also be included (see list below). If an author's affiliation has changed since the work was done, the new affiliation also should be listed. For indexing purposes, 3 10 key words should be supplied in alphabetical order (see example below)
Authors (first name and initials followed by surname, e.g., Juan X. Alvarez)
Affiliations (if multiple affiliations are listed, indicate with lowercase letter footnotes following the respective authors names)
Contact information for corresponding author, including full mailing address, telephone number, fax number, and e-mail address
For indexing purposes, 3 10 keywords should be supplied (in alphabetical order) as follows:
Keywords Benign prostatic hyperplasia; Doxazosin; Lower urinary tract symptoms
Word count of text: include the abstract but not the references in this count
Word count of the abstract (please remember Abstracts cannot exceed 300 words)
Include a structured abstract of no more than 300 words for original, review and surgery in motion articles. (See instructions above for preparing structured abstracts.) Abstracts are not required for editorials. No information should be reported in the abstract that does not appear in the text of the manuscript.
Do not use automatically generated numbering or bulleting systems or hidden text (e.g., for headings, references, footnotes, lists).
Units of Measurement
Units of measurements must conform to the Systeme International (SI): year(s), yr; month(s), mo; days, d; hours, h; minutes, min; seconds, s; grams, g; liters, l; meters, m; sample size, n; degrees of freedom, df; standard error of the mean, SE; standard deviation, SD; probability, p.
Numerals and Abbreviations
Use numerals for all values greater than ten and those followed by a unit; otherwise, spell out (e.g., 18 patients, 0.8 g/ml, 47%, 37 8C, six cases). Spell out numbers at the beginning of a sentence. Abbreviations must be defined at first use in each of the following: text, tables, and figure legends.
The ''Acknowledgments section is the general term for the list of contributions, credits, and other information included at the end of the text of a manuscript but before the references. Authors should obtain written permission to include the names of individuals in the Acknowledgment section.
In the text, references should be cited in numerical order, with citation numbers placed in square brackets.
Personal communications (pers. comm.) and unpublished data (unpubl. data) are mentioned only in the text: (pers. comm., A. Brown, Ithaca, NewYork, USA).
Each reference number should correspond to a single published source.
List all authors up to six; for more than six authors list the first three followed by ''et al.
Use Index Medicus abbreviations for journals. Provide full page ranges, using the abbreviated format shown below.
 MacDonald R, Fink HA, Huckabay C, Monga M, Wilt TJ. Botulinum toxin for treatment of urinary incontinence due to detrusor overactivity: a systematic review of effectiveness and adverse effects. Spinal Cord 2007;45:535-41.
 Filocamo M, Li Marzi V, Del Popolo G, et al. Pharmacologic treatment in postprostatectomy stress urinary incontinence. Eur Urol 2007;51:1559-64.
 Hatzimouratidis K, Hatzichristou D. Testosterone and erectile function: an unresolved enigma. Eur Urol 2007;52:26-8.Book
 King RC, Stansfield WD. A dictionary of genetics, ed. 3. New York: Oxford University Press; 2002.
 Hunskaar S, Burgio K, Diokno AC, Herzog AR, Hjalmas K, Lapitan MC. Epidemiology and natural history of urinary incontinence. In: Abrams P, Cardoza L, Khoury S, Wein A, editors. Incontinence: 2nd International Consultation on Incontinence, ed. 2. Plymouth, UK: Health Publications, 2002. p. 165-201.
Thesis or Dissertation
 Kato H. Neuroendocrine cells: their effect on the development of benign prostatic hyperplasia. Ph.D. diss. [MS thesis], University of Tokyo Medical School, Tokyo, 1997.
Compose tables in a word-processing program; do not insert as graphic elements. Number tables with Arabic numerals in the order they appear in the text. Place each table on a separate page. Provide a title at the top of each table.
Explain abbreviations and include any other comments in a note at the bottom of each table.
Figures must supplement, not duplicate, the tables and text.
Illustrations must clearly convey their message and be of high quality and sufficient size and clarity (especially lettering, arrows, and data points) to be interpretable when reduced for publication.
Number figures with Arabic numerals in the order they appear in the text.
Provide a separate list of figure legends at the end of the text; do not place legends on the figures.
Do not embed artwork within the text; figures should be supplied as separate files.
Guidelines for submitting figures in an electronic format can be found at http://www.elsevier.com/wps/find/authors.authors/authorartworkinstructions/ under Artwork Instructions.
Prior to submitting a manuscript to European Urology, authors must ensure that each requirement listed above is met. Manuscripts that do not meet these requirements will be returned to the author without review.